Head of Safety, Biosimilars
Senior Director Analytical Chemistry, CIPF and Associate Editor
Programme Director, Medicines and Prescribing Center
Assistant Professor of Pharmacology
Erasmus Medical Center
Vice President, Biotechnology PAREXEL
Medical Director, Department of Drug Information, Norwegian Medicines Agency
Ingrid Schwarzenberger, Head Global Regulatory Affairs, Sandoz Biopharmaceuticals
Adam Levysohn , Head of Global Market Access Biogen Biosimilars Business Unit, Biogen
The World Biosimilar Congress is a commercially focused event bringing together the full value chain and located in one of the world’s major life science hubs, Basel. Consisting of thought-leaders from across the globe, the World Biosimilar Congress looks at commercialising and pushing forward the adoption of biosimilars globally. Over the last 5 years, the Congress has built up a reputation for delivering high level content and bringing together the senior executives from sourcing through to patient. It is co-located with the European Antibody Congress, World Immunotherapy Congress, and HPAPI World Congress.
The World Biosimilar Congress recognises the importance of networking and offers an experience which allows you to do just that. With a series of round table discussions, speed networking, networking drinks receptions, breaks and lunches, we provide you with plenty of opportunities to have those all important conversations. With multiple networking formats we enable you to have casual chats and introductions without compromising your time attending the conference sessions.